UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example MedicinalProductDefinition: DZPorifarm-5mg-Solution-SE-IS-MPD

Generated Narrative: MedicinalProductDefinition DZPorifarm-5mg-Solution-SE-IS-MPD

identifier: http://ema.europa.eu/fhir/mpId/SE-100002342-00057369, http://ema.europa.eu/fhir/eurdId/1029

domain: Human use

status: Current

combinedPharmaceuticalDoseForm: Tablet

indication:

Diazepam påverkar de vid ångestsyndrom vanliga symtomen ängslan, ångest, rastlöshet och därav följande sömnsvårigheter. Vid depressioner med inslag av nämnda symtom kan Diazepam Orifarm ges i kombination med antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom i samband med alkoholmissbruk. Cerebralt och perifert betingade muskelspasmer. Premedicinering.

legalStatusOfSupply: Medicinal product subject to special medical prescription

classification: N05BA01

name

productName: Diazepam Orifarm 5 mg Tablett

part

part: Diazepam Orifarm

type: Invented name part

part

part: 5 mg

type: Strength part

part

part: Tablett

type: Pharmaceutical dose form part

Usages

-CountryLanguage
*Kingdom of SwedenSwedish